☰

Arash A. Alizadeh, Ph.D. - Publications

Affiliations: 
2003 Stanford University, Palo Alto, CA 
Area:
gene expression
Tree Info Grants Similar researchers PubMed Report error

117 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Chabon JJ, Hamilton EG, Kurtz DM, Esfahani MS, Moding EJ, Stehr H, Schroers-Martin J, Nabet BY, Chen B, Chaudhuri AA, Liu CL, Hui AB, Jin MC, Azad TD, Almanza D, ... ... Alizadeh AA, et al. Integrating genomic features for non-invasive early lung cancer detection. Nature. 580: 245-251. PMID 32269342 DOI: 10.1038/S41586-020-2140-0  0.494
2020 Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, Rowe SP, Ross AE, Gorin MA, Deville C, Greco SC, Wang H, Denmeade SR, Paller CJ, Dipasquale S, ... ... Alizadeh AA, et al. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial. Jama Oncology. PMID 32215577 DOI: 10.1001/Jamaoncol.2020.0147  0.407
2020 Hellmann MD, Nabet BY, Rizvi H, Chaudhuri AA, Wells DK, Dunphy MP, Chabon JJ, Liu CL, Hui AB, Arbour KC, Luo J, Preeshagul IR, Moding EJ, Almanza D, Bonilla RF, ... ... Alizadeh AA, et al. Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32046999 DOI: 10.1158/1078-0432.Ccr-19-3418  0.474
2020 King D, Alizadeh AA, Fisher GA. Detection of circulating tumor DNA in pancreas cancer. Journal of Clinical Oncology. 38: 645-645. DOI: 10.1200/jco.2020.38.4_suppl.645  0.342
2020 Newman AM, Nakao A, Li K, Wilson DC, Liu C, Diehn M, Alizadeh AA. Analytical validation of iSort digital cytometry for leukocyte enumeration in clinical tumor specimens. Journal of Clinical Oncology. 38: e15243-e15243. DOI: 10.1200/Jco.2020.38.15_Suppl.E15243  0.524
2020 Murciano-Goroff YR, Hui AB, Chabon JJ, Moding EJ, Lebow ES, Araujo-Filho JA, Isbell JM, Jones DR, Ginsberg MS, Myers ML, Offin M, Drilon AE, Hellmann MD, Lai WV, Reis-Filho JS, ... ... Alizadeh AA, et al. Early ctDNA response assessment for prediction of platinum sensitivity in small cell lung cancer. Journal of Clinical Oncology. 38: 9067-9067. DOI: 10.1200/Jco.2020.38.15_Suppl.9067  0.513
2020 Moding EJ, Esfahani MS, Nabet B, Liu Y, Chabon JJ, He J, Qiao Y, Xu T, Yao L, Gandhi S, Liao ZX, Das M, Ramchandran K, Padda SK, Neal JW, ... ... Alizadeh AA, et al. A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction. Journal of Clinical Oncology. 38: 9046-9046. DOI: 10.1200/Jco.2020.38.15_Suppl.9046  0.502
2020 Binkley MS, Jeon Y, Nesselbush M, Moding EJ, Nabet B, Almanza DS, Yoo C, Kurtz DM, Owen SG, Backhus LM, Berry MF, Shrager JB, Ramchandran K, Padda SK, Das M, ... ... Alizadeh AA, et al. KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer. Journal of Clinical Oncology. 38: 9012-9012. DOI: 10.1200/Jco.2020.38.15_Suppl.9012  0.508
2020 Newman AM, Nakao A, Li K, Liu C, Mathi K, Sigal N, Maecker H, Diehn M, Alizadeh AA. Analytical validation of digital cytometry (iSort) for leukocyte enumeration using stored blood. Journal of Clinical Oncology. 38: 3542-3542. DOI: 10.1200/Jco.2020.38.15_Suppl.3542  0.461
2019 Esfahani MS, Lee LJ, Jeon YJ, Flynn RA, Stehr H, Hui AB, Ishisoko N, Kildebeck E, Newman AM, Bratman SV, Porteus MH, Chang HY, Alizadeh AA, Diehn M. Functional significance of U2AF1 S34F mutations in lung adenocarcinomas. Nature Communications. 10: 5712. PMID 31836708 DOI: 10.1038/S41467-019-13392-Y  0.577
2019 Azad TD, Chaudhuri AA, Fang P, Qiao Y, Esfahani MS, Chabon JJ, Hamilton EG, Yang YD, Lovejoy A, Newman AM, Kurtz DM, Jin M, Schroers-Martin J, Stehr H, Liu CL, ... ... Alizadeh AA, et al. Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer. Gastroenterology. PMID 31711920 DOI: 10.1053/J.Gastro.2019.10.039  0.519
2019 Chen B, Khodadoust MS, Olsson N, Wagar LE, Fast E, Liu CL, Muftuoglu Y, Sworder BJ, Diehn M, Levy R, Davis MM, Elias JE, Altman RB, Alizadeh AA. Predicting HLA class II antigen presentation through integrated deep learning. Nature Biotechnology. PMID 31611695 DOI: 10.1038/S41587-019-0280-2  0.441
2019 Kurtz DM, Esfahani MS, Scherer F, Soo J, Jin MC, Liu CL, Newman AM, Dührsen U, Hüttmann A, Casasnovas O, Westin JR, Ritgen M, Böttcher S, Langerak AW, Roschewski M, ... ... Alizadeh AA, et al. Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction. Cell. PMID 31280963 DOI: 10.1016/J.Cell.2019.06.011  0.485
2019 Jain N, Hartert K, Tadros S, Fiskus W, Havranek O, Ma MCJ, Bouska A, Heavican T, Kumar D, Deng Q, Moore D, Pak C, Liu CL, Gentles AJ, Hartmann E, ... ... Alizadeh AA, et al. Targetable genetic alterations of () drive immunoglobulin expression in diffuse large B cell lymphoma. Science Translational Medicine. 11. PMID 31217338 DOI: 10.1126/Scitranslmed.Aav5599  0.329
2019 Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, Diehn M, Alizadeh AA. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nature Biotechnology. PMID 31061481 DOI: 10.1038/S41587-019-0114-2  0.502
2019 Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Newman AM, ... ... Alizadeh AA, et al. Reply to J. Wang et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801907. PMID 30753108 DOI: 10.1200/Jco.18.01907  0.364
2019 Moding EJ, Liu Y, Nabet B, Chabon JJ, Chaudhuri A, Hui AB, He J, Qiao Y, Heymach J, Tsao AS, Liao ZX, Gomez DR, Ramchandran K, Neal JW, Wakelee HA, ... ... Alizadeh AA, et al. ctDNA analysis for personalization of consolidation immunotherapy in localized non-small cell lung cancer. Journal of Clinical Oncology. 37: 2547-2547. DOI: 10.1200/Jco.2019.37.15_Suppl.2547  0.466
2019 Esfahani MS, Alig S, Kurtz DM, Soo J, Jin MC, Macaulay C, Craig AFM, Garofalo A, Steen CB, Scherer F, Sworder B, Diehn M, Alizadeh AA. Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling Blood. 134: 551-551. DOI: 10.1182/Blood-2019-132069  0.46
2019 Garofalo A, Schroers-Martin JG, Soo J, Kurtz DM, Sworder B, Liu CL, Pinsky BA, Luikart H, Advani RH, Natkunam Y, Khush K, Diehn M, Alizadeh AA. Deep Sequencing of Viral Cell-Free DNA for Noninvasive Detection of Immunosuppression-Related Lymphoid Malignancies Blood. 134: 885-885. DOI: 10.1182/Blood-2019-131602  0.537
2019 Macaulay C, Alig S, Kurtz DM, Jin MC, Opat S, Soo J, Sworder B, Hertzberg MS, Gandhi MK, Diehn M, Alizadeh AA. Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL Blood. 134: 1600-1600. DOI: 10.1182/Blood-2019-131278  0.482
2019 Kurtz DM, Soo J, Alig S, Keh LCT, Macaulay C, Jin MC, Scherer F, Hamilton EG, Liu CL, Chen B, Craig AFM, Diehn M, Alizadeh AA. Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA Blood. 134: 552-552. DOI: 10.1182/Blood-2019-131267  0.528
2019 Steen CB, Luca BA, Esfahani MS, Nabet BY, Sworder B, Farshidfar F, Shamardani K, Kurtz DM, Liu CL, Advani RH, Natkunam Y, Myklebust JH, Diehn M, Gentles A, Newman AM, ... Alizadeh AA, et al. An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma Blood. 134: 655-655. DOI: 10.1182/Blood-2019-129461  0.537
2019 Kathuria KR, Chen B, Khodadoust MS, Olsson N, Davis MM, Elias JE, Levy R, Altman RB, Alizadeh AA. Maria-I: A Deep-Learning Approach for Accurate Prediction of MHC Class I Tumor Neoantigen Presentation Blood. 134: 84-84. DOI: 10.1182/Blood-2019-129334  0.339
2019 Alig S, Macaulay C, Kurtz DM, Dührsen U, Hüttmann A, Jin MC, Sworder B, Garofalo A, Esfahani MS, Soo J, Scherer F, Craig A, Casasnovas O, Westin JR, Gaidano G, ... ... Alizadeh AA, et al. Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma Blood. 134: 491-491. DOI: 10.1182/Blood-2019-129283  0.495
2019 Sworder B, Kurtz DM, Macaulay C, Frank MJ, Alig S, Garofalo A, Sahaf B, Esfahani MS, Spiegel JY, Oak J, Beygi S, Jin MC, Chabon JJ, Khodadoust MS, Majzner RG, ... ... Alizadeh AA, et al. Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy Blood. 134: 550-550. DOI: 10.1182/Blood-2019-129015  0.53
2019 Moding E, Nabet B, Liu Y, Chabon J, Chaudhuri A, Hui A, Binkley M, He J, Qiao Y, Xu T, Yao L, Gandhi S, Liao Z, Das M, Ramchandran K, ... ... Alizadeh A, et al. Circulating Tumor DNA Changes During Chemoradiation for Lung Cancer Predict Patient Outcomes International Journal of Radiation Oncology*Biology*Physics. 105: S113. DOI: 10.1016/J.Ijrobp.2019.06.610  0.516
2018 Dudley JC, Schroers-Martin J, Lazzareschi DV, Shi WY, Chen SB, Esfahani MS, Trivedi D, Chabon JJ, Chaudhuri AA, Stehr H, Liu CL, Lim H, Costa HA, Nabet BY, Sin MLY, ... ... Alizadeh AA, et al. Detection and surveillance of bladder cancer using urine tumor DNA. Cancer Discovery. PMID 30578357 DOI: 10.1158/2159-8290.Cd-18-0825  0.509
2018 Reid S, Newman AM, Diehn M, Alizadeh AA, Tibshirani R. Genomic Feature Selection by Coverage Design Optimization. Journal of Applied Statistics. 45: 2658-2676. PMID 30294060 DOI: 10.1080/02664763.2018.1432577  0.487
2018 Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Levy R, ... ... Alizadeh AA, et al. Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018785246. PMID 30125215 DOI: 10.1200/Jco.2018.78.5246  0.497
2018 Erdrich J, Schaberg K, Khodadoust MS, Zhou L, Shelton AA, Visser BC, Ford JM, Alizadeh AA, Quake SR, Kunz PL, Beausang JF. Surgical and molecular characterization of primary and metastatic disease in a neuroendocrine tumor arising in a tailgut cyst. Cold Spring Harbor Molecular Case Studies. PMID 30087100 DOI: 10.1101/mcs.a003004  0.301
2018 Przybyl J, Chabon JJ, Spans L, Ganjoo K, Vennam S, Newman AM, Forgó E, Varma S, Zhu S, Debiec-Rychter M, Alizadeh AA, Diehn M, van de Rijn M. Combination approach for detecting different types of alterations in circulating tumor DNA in leiomyosarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29463554 DOI: 10.1158/1078-0432.Ccr-17-3704  0.529
2018 Soo J, Schroers-Martin J, Garofalo A, Kurtz DM, D'Emilio N, Grimm DR, Luikart H, Diehn M, Sunwoo JB, Khush KK, Alizadeh AA. Post-transplant head and neck cancers: A prospective analysis of clinical factors for risk stratification. Journal of Clinical Oncology. 36: e18051-e18051. DOI: 10.1200/Jco.2018.36.15_Suppl.E18051  0.396
2018 Soo J, Schroers-Martin J, Garofalo A, Kurtz DM, D'Emilio N, Grimm DR, Luikart H, Van De Rijn M, Diehn M, Khush KK, Alizadeh AA. Early detection of post-transplant lymphoproliferative disorder using circulating tumor DNA. Journal of Clinical Oncology. 36: 7572-7572. DOI: 10.1200/Jco.2018.36.15_Suppl.7572  0.433
2018 Schroers-Martin JG, Garofalo A, Soo J, Jin MC, Kurtz DM, Buedts L, Dührsen U, Hüttmann A, Cottereau AS, Meignan M, Casasnovas O, Westin JR, Gaidano G, Rossi D, Roschewski M, ... ... Alizadeh AA, et al. Lymphoma Virome Dynamics Revealed By Cell-Free DNA Sequencing Blood. 132: 2861-2861. DOI: 10.1182/Blood-2018-99-119905  0.499
2018 Mehrmohamadi M, Esfahani MS, Soo J, Scherer F, Schroers-Martin JG, Chen B, Kurtz DM, Hamilton E, Liu CL, Diehn M, Alizadeh AA. Distinct Chromatin Accessibility Profiles of Lymphoma Subtypes Revealed By Targeted Cell Free DNA Profiling Blood. 132: 672-672. DOI: 10.1182/Blood-2018-99-119361  0.573
2018 Jin MC, Schroers-Martin JG, Kurtz DM, Buedts L, Esfahani MS, Macaulay C, Sworder B, Soo J, Glover C, Roschewski M, Wilson WH, Dührsen U, Hüttmann A, Rossi D, Gaidano G, ... ... Alizadeh AA, et al. Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma Blood. 132: 2838-2838. DOI: 10.1182/Blood-2018-99-119140  0.579
2018 Chen E, Chaudhuri A, Nabet B, Chabon J, Merriott D, Loo B, Alizadeh A, Diehn M. Analysis of Circulating Tumor DNA Kinetics during Stereotactic Ablative Radiation Therapy for Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e676. DOI: 10.1016/J.Ijrobp.2018.07.1826  0.523
2018 Chaudhuri AA, Nabet BY, Merriott DJ, Jin M, Chen EL, Chabon JJ, Newman AM, Stehr H, Say C, Carter JN, Walters S, Becker H, Das M, Padda SK, Loo BW, ... ... Alizadeh AA, et al. (OA02) Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Metastatic Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 101: e1-e2. DOI: 10.1016/J.Ijrobp.2018.02.041  0.525
2017 Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, ... ... Alizadeh AA, et al. Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discovery. PMID 28899864 DOI: 10.1158/2159-8290.Cd-17-0716  0.534
2017 Newman AM, Gentles AJ, Liu CL, Diehn M, Alizadeh AA. Data normalization considerations for digital tumor dissection. Genome Biology. 18: 128. PMID 28679399 DOI: 10.1186/S13059-017-1257-4  0.54
2017 Scherer F, Kurtz DM, Diehn M, Alizadeh AA. High-throughput sequencing for noninvasive disease detection in hematologic malignancies. Blood. PMID 28600337 DOI: 10.1182/Blood-2017-03-735639  0.522
2017 Chaudhuri A, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Carter JN, Merriott DJ, Liu CL, Kurtz DM, Dudley JC, Padda SK, Shrager JB, Neal JW, Wakelee HA, ... ... Alizadeh AA, et al. Analysis of circulating tumor DNA in localized lung cancer for detection of molecular residual disease and personalization of adjuvant strategies. Journal of Clinical Oncology. 35: 8519-8519. DOI: 10.1200/Jco.2017.35.15_Suppl.8519  0.54
2017 Soo J, Kurtz DM, Scherer F, Craig AF, Jin MC, Westin JR, Rossi D, Gaidano G, Advani RH, Diehn M, Alizadeh AA. Elucidation of distinct mutational patterns between diffuse large B cell lymphoma subtypes utilizing circulating tumor DNA. Journal of Clinical Oncology. 35: 7538-7538. DOI: 10.1200/Jco.2017.35.15_Suppl.7538  0.499
2017 Jin MC, Kurtz DM, Esfahani MS, Scherer F, Craig AF, Soo J, Khodadoust MS, Saganty RS, Chabon JJ, Schroers-Martin J, Stehr H, Advani RH, Rossi D, Gaidano G, Westin JR, ... ... Alizadeh AA, et al. Noninvasive detection of clinically relevant copy number alterations in diffuse large B-cell lymphoma. Journal of Clinical Oncology. 35: 7507-7507. DOI: 10.1200/Jco.2017.35.15_Suppl.7507  0.473
2017 Azad TD, Chaudhuri A, Newman AM, Stehr H, Schroers-Martin J, Chabon JJ, Fang P, Qiao Y, Liao ZX, Komaki R, Alizadeh AA, Lin SH, Diehn M. Circulating tumor DNA analysis for outcome prediction in localized esophageal cancer. Journal of Clinical Oncology. 35: 4055-4055. DOI: 10.1200/Jco.2017.35.15_Suppl.4055  0.497
2017 Diehn M, Alizadeh AA, Adams H, Lee JJ, Klassen S, Palma JF, Hinzman B, Lovejoy AF, Newman AM, Yao L, Yaung S, Balasubramanyam A, Rohr UP, Rosenthal A, Kube R, et al. Early prediction of clinical outcomes in resected stage II and III colorectal cancer (CRC) through deep sequencing of circulating tumor DNA (ctDNA). Journal of Clinical Oncology. 35: 3591-3591. DOI: 10.1200/Jco.2017.35.15_Suppl.3591  0.462
2017 Chabon J, Chaudhuri A, Azad T, Kurtz D, Stehr H, Liu C, Martin JS, Merriott D, Carter J, Ayers K, Mansfield A, Jen J, Ren H, West R, Nair V, ... ... Alizadeh A, et al. MA 13.01 Clinical and Pathological Variables Influencing Noninvasive Detection of Early Stage Lung Cancer Using Circulating Tumor DNA Journal of Thoracic Oncology. 12: S1851. DOI: 10.1016/J.Jtho.2017.09.560  0.509
2017 Chaudhuri A, Lovejoy A, Chabon J, Newman A, Stehr H, Say C, Carter J, Zhou L, West R, Shrager J, Neal J, Wakelee H, Loo B, Alizadeh A, Diehn M. MA17.07 Circulating Tumor DNA Detects Minimal Residual Disease and Predicts Outcome in Localized Lung Cancer Journal of Thoracic Oncology. 12: S445. DOI: 10.1016/J.Jtho.2016.11.520  0.511
2017 Chaudhuri A, Chabon J, Lovejoy A, Newman A, Stehr H, Azad T, Carter J, Merriott D, Liu C, Kurtz D, Gensheimer M, Shrager J, Wakelee H, Neal J, Loo B, ... Alizadeh A, et al. Comparison of Circulating Tumor DNA Analysis and Surveillance Imaging After Treatment for Localized Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 99: S114. DOI: 10.1016/J.Ijrobp.2017.06.269  0.503
2017 Azad T, Chaudhuri A, Newman A, Stehr H, Schroers-Martin J, Chabon J, Fang P, Qiao Y, Liao Z, Komaki R, Alizadeh A, Lin S, Diehn M. Pretreatment Circulating Tumor DNA for Risk Stratification of Locally Advanced Esophageal Cancer Treated With Chemoradiation and Surgery International Journal of Radiation Oncology*Biology*Physics. 99: S90-S91. DOI: 10.1016/J.Ijrobp.2017.06.218  0.49
2017 Merriott D, Chaudhuri A, Jin M, Chabon J, Newman A, Stehr H, Say C, Carter J, Walters S, Becker H, Das M, Padda S, Loo B, Wakelee H, Neal J, ... Alizadeh A, et al. Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 99: S20-S21. DOI: 10.1016/J.Ijrobp.2017.06.061  0.506
2017 Chaudhuri A, Lovejoy A, Chabon J, Newman A, Stehr H, Merriott D, Carter J, Azad T, Padda S, Gensheimer M, Wakelee H, Neal J, Loo B, Alizadeh A, Diehn M. Circulating Tumor DNA Analysis during Radiation Therapy for Localized Lung Cancer Predicts Treatment Outcome International Journal of Radiation Oncology*Biology*Physics. 99: S1-S2. DOI: 10.1016/J.Ijrobp.2017.06.021  0.505
2016 Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Thomas Purcell W, Ross Camidge D, ... ... Alizadeh AA, et al. Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nature Communications. 7: 13513. PMID 27841271 DOI: 10.1038/Ncomms13513  0.477
2016 Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BC, Poultsides GA, Advani RH, ... ... Alizadeh AA, et al. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Science Translational Medicine. 8: 364ra155. PMID 27831904 DOI: 10.1126/Scitranslmed.Aai8545  0.574
2016 Chaudhuri AA, Lovejoy AF, Chabon JJ, Newman A, Stehr H, Say C, Aggarwal S, Carter JN, West RB, Neal JW, Wakelee HA, Loo BW, Alizadeh A, Diehn M. CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S41-S42. PMID 27675925 DOI: 10.1016/J.Ijrobp.2016.06.112  0.53
2016 Jeong Y, Hoang NT, Lovejoy A, Stehr H, Newman AM, Gentles AJ, Kong W, Truong D, Martin S, Chaudhuri A, Heiser D, Zhou L, Say C, Carter JN, Hiniker SM, ... ... Alizadeh AA, et al. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Cancer Discovery. PMID 27663899 DOI: 10.1158/2159-8290.Cd-16-0127  0.529
2016 Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Purcell WT, Camidge DR, ... ... Alizadeh AA, et al. Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nature Communications. 7: 11815. PMID 27283993 DOI: 10.1038/Ncomms11815  0.465
2016 Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, Zhou L, Carter JN, West RB, Sledge GW, Shrager JB, ... ... Alizadeh AA, et al. Integrated digital error suppression for improved detection of circulating tumor DNA. Nature Biotechnology. PMID 27018799 DOI: 10.1038/Nbt.3520  0.546
2016 Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, Zhou L, Carter JN, West RB, Sledge GW, Shrager JB, ... ... Alizadeh AA, et al. Integrated digital error suppression for noninvasive detection of circulating tumor DNA in NSCLC. Journal of Clinical Oncology. 34: e20500-e20500. DOI: 10.1200/Jco.2016.34.15_Suppl.E20500  0.517
2016 Chabon JJ, Simmons A, Newman AM, Lovejoy AF, Esfahani MS, Haringsma H, Kurtz DM, Stehr H, Scherer F, Durkin KA, Otterson GA, Purcell WT, Camidge DR, Goldman JW, Sequist LV, ... ... Alizadeh AA, et al. Inter- and intra-patient heterogeneity of resistance mechanisms to the mutant EGFR selective inhibitor rociletinib. Journal of Clinical Oncology. 34: 9000-9000. DOI: 10.1200/Jco.2016.34.15_Suppl.9000  0.438
2016 Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Advani RH, Maeda LS, Gupta NK, ... ... Alizadeh AA, et al. Noninvasive molecular subtyping and risk stratification of DLBCL. Journal of Clinical Oncology. 34: 7554-7554. DOI: 10.1200/Jco.2016.34.15_Suppl.7554  0.515
2016 Kurtz DM, Scherer F, Newman AM, Craig AF, Khodadoust MS, Lovejoy AF, Klass DM, Chabon JJ, Glover C, Zhou L, Liu CL, Gupta NK, Maeda LS, Advani RH, Levy R, ... ... Alizadeh AA, et al. Prediction of therapeutic outcomes in DLBCL from circulating tumor DNA dynamics. Journal of Clinical Oncology. 34: 7511-7511. DOI: 10.1200/Jco.2016.34.15_Suppl.7511  0.501
2016 Jan M, Scherer F, Kurtz DM, Newman AM, Stehr H, Liu CL, Zhou L, Glover C, Advani RH, Maeda LS, Gupta NK, Levy R, Kunder CA, Sánchez-García I, Diehn M, ... Alizadeh AA, et al. Absence of Evidence Implicating Hematopoietic Stem Cells As Common Progenitors for DLBCL Mutations Blood. 128: 4107-4107. DOI: 10.1182/Blood.V128.22.4107.4107  0.54
2016 Kurtz DM, Scherer F, Newman AM, Craig A, Jin M, Stehr H, Chabon JJ, Esfahani M, Liu CL, Zhou L, Glover C, Visser BC, Poultsides G, Advani RH, Maeda LS, ... ... Alizadeh AA, et al. Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma Blood. 128: 2930-2930. DOI: 10.1182/Blood.V128.22.2930.2930  0.56
2016 Hartert K, Tadros S, Bouska A, Moore D, Pak C, Heavican T, Liu CL, Gentles AJ, Hartmann EM, Kridel R, Smedby KE, Juliusson G, Rosenquist R, Gascoyne RD, Rosenwald A, ... ... Alizadeh AA, et al. DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma Blood. 128: 2686-2686. DOI: 10.1182/Blood.V128.22.2686.2686  0.355
2016 Scherer F, Kurtz DM, Newman AM, Craig A, Stehr H, Zhou L, Glover C, Kohrt H, Levy R, Diehn M, Alizadeh AA. Noninvasive Detection of Ibrutinib Resistance in Non-Hodgkin Lymphoma Using Cell-Free DNA Blood. 128: 1752-1752. DOI: 10.1182/Blood.V128.22.1752.1752  0.534
2016 Scherer F, Kurtz DM, Newman AM, Shahrokh Esfahani M, Craig A, Stehr H, Lovejoy AF, Chabon JJ, Liu CL, Zhou L, Glover C, Visser BC, Poultsides G, Advani RH, Maeda LS, ... ... Alizadeh AA, et al. Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma Blood. 128: 1089-1089. DOI: 10.1182/Blood.V128.22.1089.1089  0.564
2015 Chaudhuri AA, Binkley MS, Osmundson EC, Alizadeh AA, Diehn M. Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA. Seminars in Radiation Oncology. 25: 305-12. PMID 26384278 DOI: 10.1016/J.Semradonc.2015.05.001  0.532
2015 Gentles AJ, Bratman SV, Lee LJ, Harris JP, Feng W, Nair RV, Shultz DB, Nair VS, Hoang CD, West RB, Plevritis SK, Alizadeh AA, Diehn M. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. Journal of the National Cancer Institute. 107. PMID 26286589 DOI: 10.1093/Jnci/Djv211  0.544
2015 Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nature Medicine. 21: 938-45. PMID 26193342 DOI: 10.1038/Nm.3909  0.565
2015 Kurtz DM, Green MR, Bratman SV, Scherer F, Liu CL, Kunder CA, Takahashi K, Glover C, Keane C, Kihira S, Visser B, Callahan J, Kong KA, Faham M, Corbelli KS, ... ... Alizadeh AA, et al. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 125: 3679-87. PMID 25887775 DOI: 10.1182/Blood-2015-03-635169  0.478
2015 Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nature Methods. 12: 453-7. PMID 25822800 DOI: 10.1038/Nmeth.3337  0.55
2015 Bratman SV, Newman AM, Alizadeh AA, Diehn M. Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq. Expert Review of Molecular Diagnostics. 15: 715-9. PMID 25773944 DOI: 10.1586/14737159.2015.1019476  0.542
2015 Green MR, Kihira S, Liu CL, Nair RV, Salari R, Gentles AJ, Irish J, Stehr H, Vicente-Dueñas C, Romero-Camarero I, Sanchez-Garcia I, Plevritis SK, Arber DA, Batzoglou S, Levy R, ... Alizadeh AA, et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. Proceedings of the National Academy of Sciences of the United States of America. 112: E1116-25. PMID 25713363 DOI: 10.1073/Pnas.1501199112  0.306
2015 Kurtz DM, Scherer F, Green MR, Khodadoust MS, Klass DM, Zhou L, Krishnan R, Glover C, Liu CL, Kong KA, Faham M, Levy R, Diehn M, Alizadeh AA. Distinct early response dynamics of circulating tumor DNA and circulating tumor cells during therapy of B-cell NHL. Journal of Clinical Oncology. 33: 8570-8570. DOI: 10.1200/Jco.2015.33.15_Suppl.8570  0.535
2015 Scherer F, Kurtz DM, Green MR, Newman AM, Klass DM, Zhou L, Krishnan R, Liu CL, Glover C, Ohgami RS, Hicks RJ, Keane C, Kong KA, Faham M, Hertzberg MS, ... ... Alizadeh AA, et al. Pre-treatment circulating tumor DNA as a biomarker for disease burden in diffuse large B cell lymphoma (DLBCL). Journal of Clinical Oncology. 33: 8539-8539. DOI: 10.1200/Jco.2015.33.15_Suppl.8539  0.55
2015 Kurtz DM, Scherer F, Newman AM, Lovejoy AF, Klass DM, Chabon JJ, Gambhir S, Diehn M, Alizadeh AA. Dynamic Noninvasive Genomic Monitoring for Outcome Prediction in Diffuse Large B-Cell Lymphoma Blood. 126: 130-130. DOI: 10.1182/Blood.V126.23.130.130  0.526
2015 Scherer F, Kurtz DM, Newman AM, Stehr H, Liu CL, Zhou L, Craig AF, Chabon JJ, Lovejoy AF, Klass DM, Glover C, Ohgami RS, Kunder CA, Visser BC, Poultsides G, ... ... Alizadeh AA, et al. Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma Blood. 126: 114-114. DOI: 10.1182/Blood.V126.23.114.114  0.549
2015 Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA. The prognostic landscape of genes and infiltrating immune cells across human cancers Nature Medicine. 21: 938-945. DOI: 10.1038/nm.3909  0.565
2015 Klass D, Newman A, Lovejoy A, Zhou L, Stehr H, Xu T, He J, Komaki R, Liao Z, Maru D, Alizadeh A, Lin S, Diehn M. Analysis of Circulating Tumor DNA in Esophageal Carcinoma Patients Treated With Chemoradiation Therapy International Journal of Radiation Oncology*Biology*Physics. 93: S104-S105. DOI: 10.1016/J.Ijrobp.2015.07.251  0.496
2014 Newman AM, Bratman SV, Stehr H, Lee LJ, Liu CL, Diehn M, Alizadeh AA. FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution. Bioinformatics (Oxford, England). 30: 3390-3. PMID 25143292 DOI: 10.1093/Bioinformatics/Btu549  0.476
2014 Green MR, Vicente-Dueñas C, Alizadeh AA, Sánchez-García I. Hit-and-run lymphomagenesis by the Bcl6 oncogene. Cell Cycle (Georgetown, Tex.). 13: 1831-2. PMID 24867153 DOI: 10.4161/Cc.29326  0.328
2014 Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, Shrager JB, Loo BW, Alizadeh AA, Diehn M. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nature Medicine. 20: 548-54. PMID 24705333 DOI: 10.1038/Nm.3519  0.572
2014 Kurtz DM, Green MR, Bratman SV, Liu C, Glover C, Keane C, Kong K, Faham M, Miklos DB, Advani RH, Levy R, Hertzberg MS, Gandhi MK, Diehn M, Alizadeh AA. Noninvasive monitoring of cellular versus acellular tumor DNA from immunoglobulin genes for DLBCL. Journal of Clinical Oncology. 32: 8504-8504. DOI: 10.1200/Jco.2014.32.15_Suppl.8504  0.508
2014 Diehn M, Bratman S, Newman A, Neal J, Wakelee H, Merritt R, Shrager J, Loo B, Alizadeh A. Ultrasensitive Detection of Circulating Tumor DNA in Non-Small Cell Lung Cancer by Deep Sequencing International Journal of Radiation Oncology*Biology*Physics. 90: S75. DOI: 10.1016/J.Ijrobp.2014.08.315  0.538
2014 Osmundson E, Newman A, Bratman S, Klass D, Zhou L, Pai J, Longacre T, Alizadeh A, Koong A, Diehn M. Circulating Tumor DNA as a Biomarker for Pancreatic Adenocarcinoma International Journal of Radiation Oncology*Biology*Physics. 90: S816-S817. DOI: 10.1016/J.Ijrobp.2014.05.2354  0.493
2014 Modlin L, Bratman S, Newman A, Eclov N, Neal J, Wakelee H, Shrager J, Loo B, Alizadeh A, Diehn M. Circulating Tumor DNA Concentrations Reflect Metabolic Tumor Volume in NSCLC International Journal of Radiation Oncology*Biology*Physics. 90: S812. DOI: 10.1016/J.Ijrobp.2014.05.2342  0.495
2013 Bratman S, Newman A, To J, Wynne J, Neal J, Wakelee H, Shrager J, Loo B, Alizadeh A, Diehn M. Noninvasive and Ultrasensitive Quantitation of Circulating Tumor DNA by Hybrid Capture and Deep Sequencing International Journal of Radiation Oncology*Biology*Physics. 87: S92. DOI: 10.1200/Jco.2014.32.15_Suppl.11016  0.564
2012 Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, Willingham SB, Pazhanisamy SK, Contreras-Trujillo H, Storm TA, Lotan Y, Beck AH, Chung BI, Alizadeh AA, Godoy G, et al. Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proceedings of the National Academy of Sciences of the United States of America. 109: 2078-83. PMID 22308455 DOI: 10.1073/Pnas.1120605109  0.31
2012 Newman AM, Gentles AJ, Plevritis SK, Alizadeh AA. Systematic Deconvolution of Hematolymphoid Tumor Transcriptomes Reveals Infiltrating Immune Cell Signatures Related to Survival. Blood. 120: 2390-2390. DOI: 10.1182/Blood.V120.21.2390.2390  0.351
2012 Bratman S, Eclov N, Modlin L, Neal J, Loo B, Wu G, Richardson K, Newman A, Alizadeh A, Diehn M. Cell-free DNA as a Biomarker of Residual Disease Following Radiation Therapy for Non-small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S713. DOI: 10.1016/J.Ijrobp.2012.07.1908  0.491
2011 Brody J, Advani R, Weng W, Czerwinski D, Alizadeh AA, Kohrt HE, Negrin R, Levy R. Immunotransplant for mantle cell lymphoma: Phase I/II study preliminary results. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2509. PMID 28022395 DOI: 10.1182/Blood.V118.21.3068.3068  0.344
2011 Alizadeh AA, Gentles AJ, Alencar AJ, Liu CL, Kohrt HE, Houot R, Goldstein MJ, Zhao S, Natkunam Y, Advani RH, Gascoyne RD, Briones J, Tibshirani RJ, Myklebust JH, Plevritis SK, et al. Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. Blood. 118: 1350-8. PMID 21670469 DOI: 10.1182/Blood-2011-03-345272  0.356
2011 Pachynski RK, Zabel B, Tejeda N, Monnier J, Holzer AK, Gentles A, Kohrt HE, Hadeiba H, Alizadeh AA, Butcher E. Is the chemoattractant chemerin a natural tumor-suppressive cytokine? Journal of Clinical Oncology. 29. DOI: 10.1200/Jco.2012.30.15_Suppl.E21071  0.427
2009 Alizadeh AA, Gentles AJ, Alencar AJ, Kohrt HE, Houot R, Talreja N, Shyam R, Natkunam Y, Gascoyne RD, Briones J, Advani R, Lossos IS, Levy R. Prediction of Survival in Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes: Integration of Tumor and Microenvironment Contributions. Blood. 114: 622-622. DOI: 10.1182/blood.v114.22.622.622  0.33
2007 Chiu CY, Alizadeh AA, Rouskin S, Merker JD, Yeh E, Yagi S, Schnurr D, Patterson BK, Ganem D, DeRisi JL. Diagnosis of a critical respiratory illness caused by human metapneumovirus by use of a pan-virus microarray. Journal of Clinical Microbiology. 45: 2340-3. PMID 17494722 DOI: 10.1128/Jcm.00364-07  0.419
2006 Palmer C, Diehn M, Alizadeh AA, Brown PO. Cell-type specific gene expression profiles of leukocytes in human peripheral blood. Bmc Genomics. 7: 115. PMID 16704732 DOI: 10.1186/1471-2164-7-115  0.716
2004 Lossos IS, Levy R, Alizadeh AA. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. Leukemia. 18: 1775-9. PMID 15385936 DOI: 10.1038/sj.leu.2403488  0.315
2004 Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, van de Rijn M, Botstein D, Brown PO. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. Plos Biology. 2: E7. PMID 14737219 DOI: 10.1371/Journal.Pbio.0020007  0.779
2003 Roose JP, Diehn M, Tomlinson MG, Lin J, Alizadeh AA, Botstein D, Brown PO, Weiss A. T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. Plos Biology. 1: E53. PMID 14624253 DOI: 10.1371/Journal.Pbio.0000053  0.571
2003 Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO. Individuality and variation in gene expression patterns in human blood. Proceedings of the National Academy of Sciences of the United States of America. 100: 1896-901. PMID 12578971 DOI: 10.1073/Pnas.252784499  0.606
2003 Diehn M, Sherlock G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T, Rees CA, Cherry JM, Botstein D, Brown PO, Alizadeh AA. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Research. 31: 219-23. PMID 12519986 DOI: 10.1093/Nar/Gkg014  0.599
2002 Diehn M, Alizadeh AA, Rando OJ, Liu CL, Stankunas K, Botstein D, Crabtree GR, Brown PO. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proceedings of the National Academy of Sciences of the United States of America. 99: 11796-801. PMID 12195013 DOI: 10.1073/Pnas.092284399  0.567
2002 Lossos IS, Alizadeh AA, Diehn M, Warnke R, Thorstenson Y, Oefner PJ, Brown PO, Botstein D, Levy R. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proceedings of the National Academy of Sciences of the United States of America. 99: 8886-91. PMID 12077300 DOI: 10.1073/Pnas.132253599  0.604
2002 Clément K, Viguerie N, Diehn M, Alizadeh A, Barbe P, Thalamas C, Storey JD, Brown PO, Barsh GS, Langin D. In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Research. 12: 281-91. PMID 11827947 DOI: 10.1101/Gr.207702  0.582
2002 Boldrick JC, Alizadeh AA, Diehn M, Dudoit S, Liu CL, Belcher CE, Botstein D, Staudt LM, Brown PO, Relman DA. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proceedings of the National Academy of Sciences of the United States of America. 99: 972-7. PMID 11805339 DOI: 10.1073/Pnas.231625398  0.565
2001 Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. The Journal of Experimental Medicine. 194: 1639-47. PMID 11733578 DOI: 10.1084/Jem.194.11.1639  0.52
2001 Sarwal M, Chang S, Barry C, Chen X, Alizadeh A, Salvatierra O, Brown P. Genomic analysis of renal allograft dysfunction using cDNA microarrays Transplantation Proceedings. 33: 297-298. PMID 11266826 DOI: 10.1016/S0041-1345(01)01917-0  0.372
2000 Hastie T, Tibshirani R, Eisen MB, Alizadeh A, Levy R, Staudt L, Chan WC, Botstein D, Brown P. 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biology. 1: RESEARCH0003. PMID 11178228 DOI: 10.1186/Gb-2000-1-2-Research0003  0.722
2000 Lossos IS, Alizadeh AA, Eisen MB, Chan WC, Brown PO, Botstein D, Staudt LM, Levy R. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 97: 10209-13. PMID 10954754 DOI: 10.1073/Pnas.180316097  0.739
2000 Diehn M, Alizadeh AA, Brown PO. Examining the living genome in health and disease with DNA microarrays. Jama. 283: 2298-9. PMID 10807394 DOI: 10.1001/Jama.283.17.2298-Jms0503-4-1  0.568
2000 Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403: 503-11. PMID 10676951 DOI: 10.1038/35000501  0.736
1999 Alizadeh A, Eisen M, Davis RE, Ma C, Sabet H, Tran T, Powell JI, Yang L, Marti GE, Moore DT, Hudson JR, Chan WC, Greiner T, Weisenburger D, Armitage JO, et al. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harbor Symposia On Quantitative Biology. 64: 71-8. PMID 11232339 DOI: 10.1101/Sqb.1999.64.71  0.722
1999 Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genetics. 23: 41-6. PMID 10471496 DOI: 10.1038/12640  0.72
1999 Pollack JR, Perou CM, Sorlie T, Alizadeh AA, Rees C, Eise MB, Pergamenschikov A, Williams CF, van de Rijn M, Jeffrey SS, Johnsen H, Lonning PE, Geisler S, Aas T, Borresen-Dale A, et al. Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays Nature Genetics. 23: 69-69. DOI: 10.1038/14385  0.44
1999 Alizadeh A, Eisen MB, Davis RE, Powell JI, Yang L, Hart RR, Sabet H, Tran TH, Yu X, Ma C, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Lossos I, et al. Analysis of gene expression in normal and malignant lymphocytes using the Lymphochip cDNA microarray Nature Genetics. 23: 30-31. DOI: 10.1038/14260  0.726
1998 Alizadeh A, Eisen M, Botstein D, Brown PO, Staudt LM. Probing lymphocyte biology by genomic-scale gene expression analysis Journal of Clinical Immunology. 18: 373-379. PMID 9857281 DOI: 10.1023/A:1023293621057  0.73
Show low-probability matches.